期刊文献+

哮喘慢性持续期肺功能与生存质量的关系 被引量:6

Correlation between lung function and life quality of the patients with asthma in chronic duration
下载PDF
导出
摘要 目的:探讨哮喘慢性持续期肺功能与生存质量的关系。方法:120例确诊为哮喘慢性持续期的患者填写哮喘生存质量问卷(AQLQ),记录日间及夜间症状评分并进行肺功能测试,其中99例经规范治疗(90 ± 15) d后依嘱复诊并再次填写AQLQ量表,记录日间及夜间症状评分并进行肺功能测试。按FEV1占预计值百分比(FEV1%)将治疗前后的患者各分为两组, FEV1%≥80%为A组, FEV1%≤79%为B组。观察患者肺功能与生存质量的关系。结果:无论治疗前还是治疗后,A组FEV1、FEV1%、PEF、PEF %和AQLQ均显著高于B组(P < 0.05),且AQLQ得分与FEV1%和PEF %结果高度一致;治疗前,AQLQ得分与FEV1(r =0.84)、FEV1%(r = 0.65)、PEF(r = 0.63)和PEF% (r = 0.44)均呈正相关(P < 0.01),治疗后,AQLQ得分仍与FEV1(r = 0.89)、FEV1%(r = 0.77)、PEF(r = 0.62)和PEF% (r = 0.50)呈正相关(P < 0.01)。结论:哮喘患者肺功能与生存质量密切相关,肺功能联合生存质量量表能更全面地反映患者病情的严重程度。 Objective To investigate the correlation between lung function and life quality of the patients with asthma in chronic duration.Methods 120 patients who were diagnosed as asthma and asked to fill in the asthma quality of life questionnaire (AQLQ),and test pulmonary function simultaneously,their daytime and nighttime symptom scores were also recorded respectively.After (90 ± 15) days' regular treatment,99 cases of them filled in the AQLQ scale and received pulmonary function test once again.The patients were divided into two groups depending on FEV1% before or after treatment respectively,FEV1% ≥ 80% for the A group,FEV1% ≤ 79% for the B group,so as to observe the correlation between lung function and life quality.Results No matter before or after treatment,FEV1,FEV1%,PEF,PEF% or AQLQ score showed significant difference (P 0.05) between the two groups and the AQLQ showed a good correlation and consistency with FEV1% and PEF%.AQLQ was positively correlated with FEV1,FEV1%,PEF,PEF% and there was significant difference(P 0.05).Conclusion The pulmonary function of asthmatic patients is closely related with the quality of life,it is more comprehensively assess the severity of patients to joint the pulmonary function and the AQLQ score.
出处 《实用医学杂志》 CAS 北大核心 2011年第19期3510-3512,共3页 The Journal of Practical Medicine
基金 中华医学会慢性呼吸道疾病专项基金项目(编号:08020460124)
关键词 哮喘 肺功能 哮喘生存质量问卷(AQLQ) Asthma Pulmonary function test Asthma quality of life questionnaire
  • 相关文献

参考文献9

二级参考文献22

  • 1Global Initiative for Asthma (GINA)2008. Available from http://www. ginasthma. org 2008.
  • 2Lugogo N L, Monica K. Epidemiology of asthma [J ]. Clin Chest Med, 2006, 27: 1.
  • 3Beuther D A, Sutherland E R. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies[J]. Am J Respir Crit Care Med, 2007, 175: 661.
  • 4Boulet L P, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma[J]. Respir Med, 2007, 101: 2240.
  • 5Hogaboam C M, Carpenter K J, Schuh J M, et al. Aspergillus and asthma- - any link[J]. Med Mycol, 2005, 1: S197.
  • 6Braun- Fahrlander C. Environmental exposure to endotoxin and other microbial products and the decreased risk of childhood atopy: evaluating developments since April 2002 [J ]. Curr Opin Allergy Clin Immunol, 2003, 3(5) : 325.
  • 7Malo J L, Lemiere C, Gautrin D, et al. Occupational asthma [J]. Curr Opin Pulm Med, 2004, 10(1) : 57.
  • 8Litonjua A A. Dietary factors and development of asthma[J]. Immunol Allergy Clin N Am, 2008, 28 : 603.
  • 9Devereux G, Seaton A. Diet as a risk factor for atopy and asthma[J].J Allergy Clin Immunol, 2005, 115: 1109.
  • 10Hemelaers L, Louis R. Eotaxin: an important chemokine in asthma [ J ]. Rev Med Liege, 2006,61 (4) : 223 -226.

共引文献2541

同被引文献48

  • 1中华全国中医学会内科学会.哮喘病诊断及疗效评定标准(修订稿)[J].中国医药学报,1988,3(3):67-67.
  • 2陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 3GREISNER WA 3rd, SETTIPANE RJ, SETTIPANE GA. The course of asthma parallels that of allergic rhinitis: a 23-year follow-up study of college students[J]. Allergy Asthma Proc,2000,21(6) :371-375.
  • 4Centers for Disease Control and Prevention (CDC). Vital signs: asthma prevalence, disease characteristics, and self management education: United States,2001-2009[-J:. MM- WR Moth Mortal Wkly Rep, 2011,60 .. 547-552.
  • 5Moorman JE, Zahran H, Truman BI, et al. Current asthma prevalence: United States, 2006-2008EJ-]. MMWR Surveill Suture, 2011,60(Suppl 17) : 84-86.
  • 6Holgate ST. Innate and adaptive immune responses in asthma [-J3. Nat Med,2012,18(5) :673-683.
  • 7Naclerio RM, Bachert C, Baraniuk JN. Pathophysiology of nasal congestion:J3. Int J Gen Meal, 2010,3 : 47-57.
  • 8Bochner BS, Gleich GJ. What targeting eosinophils has taught us about their role in diseasesEJ:. J Allergy Clin Im- munol,2010,126(1) : 16-25.
  • 9Corren J. Inhibition of interleukin-5 for the treatment of eo sinophilic diseases:-J:. Discov Meal,2012,13(71) :305-312.
  • 10Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma EJ:. N Engl J Med, 2009,360:973 984.

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部